Friday June 14, 2019 Change -3.45% Price $3.86
Chart period: 2019-03-15 - 2019-06-14




Will ALQA stock price go up or down on Mon, 17 Jun 2019?


Alliqua BioMedical Forecast and Stock Analysis

Technical ALQA stock analysis for Friday June 14, 2019.

Sell candidate since 2019-06-14

Alliqua BioMedical fell by -3.45% in the last day ( Friday, 14th Jun 2019 ) from $4.00 to $3.86 During day the stock fluctuated 6.49% from a day low at $3.85 to a day high of $4.10. The price has been going up and down for this period, and there has been a -37.71% loss for the last 2 weeks. Volume fell in the last day along with the stock, which is actually a good sign as volume should follow the stock. In the last day the trading volume fell by -23 639 shares and in total 16 839 shares bought and sold for approximately $65 032.20.

Quick summary:

  • 30 day high of the ALQA stock price was $7.70 and low was $3.31.
  • 90 day high was $10.94 and low was $2.38.
  • 52 week high for the Alliqua BioMedical - $10.94 and low - $1.55.


Alliqua BioMedical lies in the lower part of a very wide and strong rising trend in the short term, and this will normally pose a very good buying opportunity. A break down the bottom trend line at $3.74 will firstly indicate a slower raising rate, but may also be a early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 63.13% during the next 3 months and, with 90% probability hold a price between $6.10 and $17.55 at the end of this period.

Click here for today's Top 5 Trending Companies


There are few to none technical positive signals at the moment. Alliqua BioMedical holds sales signals from both short- and long-term moving averages. In addition, there is a general sales signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up there will be some resistance from the lines at $4.65 and $5.57. A break-up above any of these levels will issue buy signals. A sales signal was issued from a pivot top point on Thursday June 13, 2019, which indicates further falls until a new bottom pivot has been found. Volume fell along with the price during the last trading day which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk. The very low volume increases the risk and reduces the other technical signals issued.

The stock had a Golden Star Signal* on Thursday June 28, 2018 in the medium-term chart.

* Golden Star Signal* is when the short-term moving average, the long-term moving average, and price line meet in a special combination. This combination is very rare and often followed by long and strong gains for the stock in question.

Access today's Top 5 Golden Star Companies

Relative Strength Index (RSI)

The stock currently holds a RSI14 at 28 and is oversold on RSI14. The stock being oversold is no guarantee for instant reaction up as some stocks may be oversold for a long time. It is important to review the previous RSI-history to get an indication of the RSI-sensitiveness.

Access full RSI 14 and RSI 21 lists

Support & Resistance

On the downside, the stock finds support just below today's level from accumulated volume at $2.97 and $2.95.

There is natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Alliqua BioMedical finds support just below today's level at $2.97. If this is broken, then the next support from accumulated volume will be at $2.95 and $2.93.

Support: $2.97 Price: $3.86 Resistance: $4.00


This stock may move much during a day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.25 between high and low, or 6.49%. For the last week the stock has had a daily average volatility of 25.33%.

Alliqua BioMedical is oversold on RSI14 (28). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.

Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.

25.33 %

Average volatility

Overall risk:

Very Low Low Medium High Very High


The Alliqua BioMedical stock holds several negative signals and despite the positive trend we believe Alliqua BioMedical will perform weak in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our recommendation for this stock since last evaluation from a Hold/Accumulate to a Sell Candidate.

Sell Candidate Downgraded

Will ALQA stock price go up or down on Mon, 17 Jun 2019?


Proudly made at

Rise Vilnius
in partnership with
Barclays Bank